Pharmaceutical giant Sun Pharmaceutical Industries is anticipated to report consistent revenue growth, albeit with subdued profitability in its results for the September 2025 quarter (Q2FY26), impacted by increased costs associated with its US
Continuing its growth journey after the major investment in Hyderabad, Eli Lilly and Company now plans to build a USD 3 billion manufacturing facility in Katwijk, the Netherlands, within the Leiden Bio Science Park. The new site will increase...
Bharat Biotech International Ltd has broadened its biologics portfolio to include the launch of Nucelion Therapeutics Pvt Ltd, a 100% owned contract research, development, and manufacturing organization (CRDMO) that focuses on the development
You're standing in the toothpaste aisle at your local supermarket. One shelf has your regular adult toothpaste, the one with strong mint and whitening power.
Reflecting strong operational performance and consistent market momentum, Cipla Limited has reported a rise in both revenue and profitability for the quarter and half year ended September 30, 2025. The company’s results highlight continued growth in
Piramal Pharma Solutions, a global contract development and manufacturing organization (CDMO) under Piramal Pharma Ltd., has signed a Memorandum of Understanding (MOU) with Korean biotech company IntoCell Inc...
The third-largest pharmaceutical business in India, Cipla, has finalized its long-discussed succession plan by confirming that Achin Gupta, its Global COO (GCOO), will be promoted to the position of Managing Director (MD) and Global CEO (GCEO) on
Swiss pharmaceutical company Novartis achieved its profit forecast for the third quarter on Tuesday, as robust growth from newer medications compensated for a significant decline in sales of its leading heart medication, Entresto, which is facing com
According to Minister for IT and Industries Duddilla Sridhar Babu, Telangana has set the lofty goal of bringing in Rs. 1 lakh crore in new investments in the life sciences sector by 2030 in order to create jobs for five lakh people
India released a list of registered interested parties on Monday, advancing an anti-dumping inquiry into imports of ethambutol hydrochloride, an active pharmaceutical ingredient used in anti-tuberculosis medications, from China and Thailand